Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

Clinical trial NCT05857085 · COMPLETED

Trial details

NCT number: NCT05857085
Sponsor: General and Teaching Hospital Celje
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Endothelial Dysfunction Diabetes Mellitus, Type 1 Biomarkers Endothelial Progenitor Cells SGLT 2 Inhibitors Incretins Glucose Excursions FMD FPF Arterial Stiffness

Start date: 2021-12-15
Primary completion: 2022-03-10
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.